Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Lucy Scientific Discovery Inc | 880.1K | --- | --- |
Lucy Scientific Discovery Inc., formerly Doseology Sciences Inc., is an early-stage psychedelic manufacturing company. The Company is focused on research, development and manufacturing for the emerging psychedelic-based medicine industry. The Company is advancing the frontiers of mind science and facilitating the development of psychotropic and psychedelic treatment therapies, medicines, and commercial products. It is engaged in developing consumer product manufacturing, marketing and distribution. The Company is dedicated to the production of a variety of natural, synthetic and biosynthetic products to meet the needs of the psychotropics-based medicine market.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $880.1K |
---|---|
Revenue (TTM) | $98.5K |
Shares Outstanding | 4.4M |
Lucy Scientific Discovery Inc does not pay a dividend. | |
Beta | --- |
EPS | $-0.09 |
Book Value | $0.23 |
P/E Ratio | --- |
Price/Sales (TTM) | 8.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -370.49% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.